Tag: Theratechnologies

August 12, 2019

Theratechnologies Files Application to List on NASDAQ

Theratechnologies (TSX:TH) has announced it has applied to list its common shares on the NASDAQ. As quoted in the press...
July 26, 2019

Theratechnologies Receives Positive Recommendation From the CHMP for Trogarzo® in the European Union

Theratechnologies (TSX:TH) has announced that the Committee for Medicinal Products for Human use has given a positive recommendation for approval...
October 29, 2018

United States Department of Health and Human Services Publishes New HIV Treatment Guidelines Including Trogarzo

Theratechnologies (TSX:TH) is pleased to announce that Trogarzo (ibalizumab-uiyk) injection is now included in the most recent version of the treatment...
September 14, 2018

European Medicines Agency Validates Marketing Authorization Application for Trogarzo

Theratechnologies (TSX:TH) is pleased to announce that the European Medicines Agency has confirmed the validity of the marketing authorization application...
August 20, 2018

European Medicines Agency Authorizes Deferral of Paediatric Investigation Plan for Trogarzo

Theratechnologies (TSX:TH) announced that the Paediatric Committee of the European Medicines Agency has accepted to defer the initiation of the...
July 5, 2018

Theratechnologies Announces Financial Results for the Second Quarter of 2018

Theratechnologies (TSX:TH) announced its financial results for the second quarter ended May 31, 2018. As quoted in the press release:...
July 4, 2018

Theratechnologies Submits Novel Single-Vial Formulation of EGRIFTA (Tesamorelin for Injection) for FDA Approval

Theratechnologies (TSX:TH) today announced that it has filed a supplemental new drug application (sNDA) with the Food and Drug Administration...